Harnessing the Immune System in the Fight Against Bacterial Infections: Current Strategies and Future Prospects

Safaa A. Al-Isaw

Safaa A. Al-Isaw Al-Furat Al-Awsat Technical University, Technical Institute of Babylon

Keywords: Antibiotic Resistance, Alternatives To Antibiotics, Antimicrobial Peptides, Bacteriophages, Antimicrobial-Resistant Enzymes, Biofilms, Antivirulence

Abstract

The problem of antibiotic resistance, or antimicrobial resistance (AMR), keeps getting worse and spreading to new areas. Because of this, it is harder or even impossible to treat Bacterial diseases, which has caused more people to get sick and die. Even though traditional antimicrobial treatment hasn't worked in the last 20 years, no new class of antibiotics has been made available. This has led to the discovery of a number of new ways to fight these multidrug-resistant infectious bacteria. The purpose of this study is to collect information and think about the methods being used or mentioned as possible replacements for common antibiotics. Methods that aren't often used, like the CRISPR-Cas system, techniques that target the enzymes or proteins that make bacteria immune to medicines, drug delivery systems, and combinations of these, are some of the things that are being done. These different methods could change how hospitals and other medical places treat germs that are resistant to many drugs.

References

Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406(6797):782–7.

Anaya JM, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R. Autoimmunity: from bench to bedside. El Rosario University Press; 2013.

Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev. 2009;227(1):221–33.

Kobayashi SD, Malachowa N, DeLeo FR. Neutrophils and bacterial immune evasion. J Innate Immun. 2018;10(5–6):432–41.

Wilson J, Hunt T. Molecular biology of the cell: a problems approach. Garland Science; 2002.

Spaan AN, Surewaard BGJ, Nijland R, van Strijp JAG. Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu Rev Microbiol. 2013;67:629–50.

Pandey S, Shukla N, Singh SS, Tripathi D, Tripathi T, Kant S. Bacterial metabolic fitness during pathogenesis; 2020.

Howden BP, Giulieri SG, Wong Fok Lung T, Baines SL, Sharkey LK, Lee JYH, et al. Staphylococcus aureus host interactions and adaptation. Nat Rev Microbiol. 2023;21(6):380–95.

Zorzoli A, Grayczyk JP, Alonzo F 3rd. Staphylococcus aureus tissue infection during sepsis is supported by differential use of bacterial or host-derived lipoic acid. PLoS Pathog. 2016;12(10):e1005933.

Traven A, Naderer T. Central metabolic interactions of immune cells and microbes: prospects for defeating infections. EMBO Rep. 2019;20(7):e47995.

Intisar Khlaif Flaifel, Ali AA, Taha RQ, Issa M, Mohsein OA, Khalid HA. Frequency and sensitivity of Proteus spp, Pseudomonas spp, and Staphylococcus spp in urine cultures. Central Asian Journal of Medical and Natural Science. 2023;4(6):889–900. https://doi.org/10.17605/cajmns.v4i6.2140

Albiger B, et al. Role of the innate immune system in host defence against bacterial infections: focus on the Toll‐like receptors. J Intern Med. 2007;261(6):511–28.

Hancock REW, Nijnik A, Philpott DJ. Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol. 2012;10(4):243–54.